Skip to content

Pyrantel

ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS

Also known as: pyrantel pamoate, pyrantel tartrate, pyrequan

YEAR INTRODUCED approvedATC P02CC01

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Pyrantel is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1974. DrugCentral lists 1 molecular target, including ACHE. Recorded indications include Ascariasis, Enterobiasis and Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata.

  • Molecular targets: ACHE (1 listed in DrugCentral).
  • Indications: Ascariasis, Enterobiasis and Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata.
  • ATC code: P02CC01 (Tetrahydropyrimidine derivatives).
  • Molecular formula: C11H14N2S; molecular weight 206.31 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (3)

  • Ascariasis
  • Enterobiasis
  • Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata

Off-label uses (5)

  • Ancylostoma Duodenale Infection
  • Infection by Moniliformis
  • Infection by Uncinaria
  • Necator Americanus Infection
  • Trichostrongyliasis

Contraindications (1)

  • Disease of liver

Mechanism & targets

Molecular targets (1)

TargetGeneActionActivity
AcetylcholinesteraseACHEunknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1974-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
P02CC01ANTIPARASITIC PRODUCTS, INSECTICIDES AND REPELLENTS › ANTHELMINTICS › ANTINEMATODAL AGENTS › Tetrahydropyrimidine derivatives

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Pyrantel is on its molecule page.

Molecular formulaC11H14N2S
Molecular weight206.31 g/mol
CAS number15686-83-6
InChIKeyYSAUAVHXTIETRK-AATRIKPKSA-N
PubChem CID708857
CN1CCCN=C1\C=C\C1=CC=CS1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Pyrantel used for?

DrugCentral lists the following indications for Pyrantel: Ascariasis, Enterobiasis and Mixed intestinal infection due to Class Cestoda and/or Class Trematoda and/or Phylum Nemata.

How does Pyrantel work?

Its molecular targets in DrugCentral include ACHE.

When was Pyrantel first approved?

Pyrantel was first approved by the YEAR INTRODUCED in 1974.

What is the chemical formula of Pyrantel?

Pyrantel has the molecular formula C11H14N2S and a molecular weight of 206.31 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1974-01-01
AgencyYEAR INTRODUCED
Targets1
Indications3
FormulaC11H14N2S
DrugCentral ID2999
Interactive profile